EXCLUSIVE: Eli Lilly gave compassionate use access to retatrutide, their unapproved powerful obesity drug, to a 79-year-old man in April. The application was arranged by a top doctor at NIH, and cleared by the FDA.
statnews.com/2026/06/23/eli… Sources told STAT that application drew interest from top health officials. Given the demographics and the peculiar nature of the application, I asked the WH if this patient was President Trump, who turned 80 a week ago. I did not get a direct answer.